Prostate Cancer Treatment Can Increase The Risk For Osteoporosis

by Medindia Content Team on  December 21, 2004 at 1:56 PM General Health News
RSS Email Print This Page Comment
Font : A-A+

Prostate Cancer Treatment Can Increase The Risk For Osteoporosis
A new study shows men with prostate cancer who receive a common medication aimed to treat disease that has spread or reduce the risk of recurrence after surgery may be at increased risk for developing osteoporosis.

The research showed men treated with androgen deprivation therapy (ADT) after prostate cancer run a higher risk of developing the bone-thinning disease most common among women. Men who are older, smoke, or suffer from alcoholism are at especially high risk.

For the study the records of 184 prostate cancer patients were reviewed to determine if their doctors ordered bone mineral density tests to assess for osteoporosis or prescribed drugs to treat the disease. Results showed only about 15 percent of the men underwent any kind of medical management for osteoporosis, and only about 5 percent received a drug to treat the condition.

Thus researchers say a lack of formal guidelines on the treatment of osteoporosis among men on ADT may be to blame for the dismal findings.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Rickets Osteoporosis Prostate Cancer Lifestyle And Osteoporosis Cancer and Homeopathy Trans-Urethral Resection of the Prostate Kyphosis Prostate Cancer Facts Cancer Facts Cancer 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive